Where better medicines begin
Scientific, regulatory, and societal upheavals in the last three years are making early-stage product development more complex. In our recent work with clients, we’ve found that a multidisciplinary approach to early-stage development is the most cost-effective way to mitigate risks while navigating this complexity. Integrating regulatory, clinical pharmacology, modeling and simulation, and biomarker strategies enables more informed advancement decisions. Companies can learn fast and lay a solid early foundation for future success with every asset in their portfolio.
In this playbook, we share our best thinking on where better medicines begin, focusing on four early-stage imperatives:
- Getting the most out of early interactions with regulators
- Using clinical pharmacology and modeling and simulation to optimize first-in-human (FIH) trial design
- Multiplying the feedback loops of learning and efficiency with biomarkers
- Planning early for patient diversity in clinical trials
Related Insights
Blog
Benedikt Egersdoerfer joins Parexel to lead Global Data Operations
Aug 28, 2024
Video
Part 1: Risk-based Quality Management (RBQM) Video Series
Nov 11, 2021
Blog
Including patients in DCT design
Sep 13, 2022
Podcast
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
May 9, 2022
Blog
End-to-end risk management: Getting the most from your program
Apr 4, 2022
Video
Part 2: Practically Speaking: Driving Clinical Transformation
Feb 9, 2022
Video
Part 1: Practically Speaking: Driving Clinical Transformation
Feb 9, 2022
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Whitepaper
Master Protocols from Design to Delivery
Sep 30, 2021
Video
FSP 2.0: Why Talent Development is the New Talent Acquisition
Oct 26, 2022
Related Insights
Blog
Benedikt Egersdoerfer joins Parexel to lead Global Data Operations
Aug 28, 2024
Video
Part 1: Risk-based Quality Management (RBQM) Video Series
Nov 11, 2021
Blog
Including patients in DCT design
Sep 13, 2022
Podcast
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
May 9, 2022
Blog
End-to-end risk management: Getting the most from your program
Apr 4, 2022
Video
Part 2: Practically Speaking: Driving Clinical Transformation
Feb 9, 2022
Video
Part 1: Practically Speaking: Driving Clinical Transformation
Feb 9, 2022
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Whitepaper
Master Protocols from Design to Delivery
Sep 30, 2021
Video
FSP 2.0: Why Talent Development is the New Talent Acquisition
Oct 26, 2022